These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14458289)

  • 21. Relationship of native heparin to clearing of an alimentary lipemia.
    LEVY SW; SWANK RL
    Proc Soc Exp Biol Med; 1953 Apr; 82(4):553-6. PubMed ID: 13055931
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
    Markoski S
    Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fibrinolytic action of heparinoid substance (L. 942) on experimentally induced venous thromboses].
    DEGNI M; de LANGLADA F
    Rev Assoc Med Bras; 1961 Aug; 7():287-90. PubMed ID: 13884866
    [No Abstract]   [Full Text] [Related]  

  • 24. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)].
    LEBLOIS J; LESAGE R; RIVET E
    Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327
    [No Abstract]   [Full Text] [Related]  

  • 25. The heparin-like action of treburon in abolishing alimentary lipemia in normal individuals.
    ACKERMAN RF; ZILVERSMIT DB
    Circulation; 1953 Apr; 7(4):581-84. PubMed ID: 13033084
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of small doses of heparin in increasing the translucence of plasma during alimentary lipemia; studies in normal persons and patients having arteriosclerosis.
    BLOCK WJ; BARKER NW; MANN FD
    Circulation; 1951 Nov; 4(5):674-8. PubMed ID: 14870279
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinolysis in relation to lipaemia and intravenous heparin in the white and Bantu.
    LACKNER H; SOUGIN-MIBASHAN R
    S Afr Med J; 1961 May; 35():364. PubMed ID: 13758091
    [No Abstract]   [Full Text] [Related]  

  • 28. OBSERVATIONS ON THE POSSIBILITY OF INFLUENCING HYPERLIPAEMIA BY DIFFERENT DRUGS.
    RETSAGI G; KELLER L; GERO S
    Gerontol Clin (Basel); 1964; 6():22-7. PubMed ID: 14105115
    [No Abstract]   [Full Text] [Related]  

  • 29. [EFFECT OF ALIMENTARY LIPEMIA ON ACTIVATION OF LIPOPROTEIN LIPASE AND POSTHEPARIN ESTERASE].
    KUCEROVA L; STORK A
    Acta Univ Carol Med (Praha); 1963; 9():493-506. PubMed ID: 14159913
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease].
    Isidori A; Butti A; Rossi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5077-81. PubMed ID: 4188592
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of aldosterone and aldosterone antagonists in patients with hypoaldosteronism caused by heparinoid].
    CEJKA V; de VRIES L; van DAATSELLAR J; BORST JG
    Ned Tijdschr Geneeskd; 1962 Mar; 106():617-20. PubMed ID: 13877617
    [No Abstract]   [Full Text] [Related]  

  • 32. [STUDIES ON THE ACTION OF A SYNTHETIC HEPARINOID (FIBROCID) IN THE COAGULATION-ANTICOAGULATION PROCESS].
    SANCHEZFAYOS J; OUTEIRINO J; ALBORES I; PANIAGUA G
    Rev Clin Esp; 1964 Aug; 94():275-9. PubMed ID: 14208057
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular lesions and changes in blood coagulation and fibrinolysis associated with diet-induced lipemia in the rat.
    NAIMI S; GOLDSTEIN R; NOTHMAN MM; WILGRAM GF; PROGER S
    J Clin Invest; 1962 Sep; 41(9):1708-19. PubMed ID: 14478022
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of a heparinoid extract on the blood lipids and basal thrombodensitogram].
    Ferri F; D'Agostino F; D'Onofrio E
    Minerva Med; 1973 Jan; 64(6):272-7. PubMed ID: 4120079
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of onion on serum cholesterol, lipoproteins and fibrinolytic activity of blood in alimentary lipaemia.
    Jain RC
    J Assoc Physicians India; 1971 Apr; 19(4):305-10. PubMed ID: 5558815
    [No Abstract]   [Full Text] [Related]  

  • 36. FIRST RESULTS ON THE TREATMENT OF DISLIPEMIAS OBTAINED WITH THE USE OF A PANCREATIC HEPARIN-LIKE SUBSTANCE.
    AZZENA D; GHIGLIOTTI G; ASTENGO F; MOLINELLI G
    G Gerontol; 1964 Feb; 12():169-70. PubMed ID: 14163027
    [No Abstract]   [Full Text] [Related]  

  • 37. [ACTION OF DUODENAL HEPARINOID ON GLUCIDE METABOLISM].
    BARBEITOARANDA A; PRESS L; GIORDANO J; LOPEZGIL AL; CAMPAGNOLI M
    Dia Med; 1963 Sep; 35():1491-3. PubMed ID: 14089621
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the clinical aspects and therapy of essential hyperlipemia].
    MAABEN JH; WETZEL H
    Med Klin; 1963 Apr; 58():547-50. PubMed ID: 13932000
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.
    de Boer A; Kluft C; Dooijewaard G; Kasper FJ; Kroon JM; Breimer DD; Stiekema JC; Cohen AF
    Thromb Haemost; 1992 Nov; 68(5):550-5. PubMed ID: 1280862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE EFFECT OF TRIPARANOL AND OF HEPARINOID ON SPONTANEOUS ATHEROSCLEROSIS OF HENS.
    MALINOW MR; MARINI MA; LEMA B; NEBBIA M; BERARDI JA
    Acta Physiol Lat Am; 1964; 14():71-6. PubMed ID: 14175168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.